Related Experiment Video
Updated: Jan 21, 2026

Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip
Published on: March 29, 2024
Role of viral and bacterial pathogens in causing pneumonia among Western Australian children: a case-control study
Mejbah Uddin Bhuiyan1,2, Thomas L Snelling2,3, Rachel West2
1Division of Paediatrics, Faculty of Health and Medical Sciences, School of Medicine, The University of Western Australia, Perth, Western Australia, Australia.
Insights
This study investigates the bacterial and viral causes of childhood pneumonia in Australia. Researchers aim to clarify pathogen contributions to community-acquired pneumonia (CAP) to improve diagnosis and prevention strategies.
Area of Science:
- Pediatrics
- Infectious Diseases
- Respiratory Medicine
Background:
- Pneumonia is a major global cause of childhood illness and death.
- Vaccines have reduced bacterial pneumonia, but viral roles and pathogen contributions to community-acquired pneumonia (CAP) remain unclear.
- Few comprehensive studies have assessed bacterial and viral causes of pneumonia in developed countries since vaccine introduction.
Purpose of the Study:
- To determine the etiological contribution of bacteria and viruses to childhood CAP.
- To inform the development of improved diagnostic, treatment, and preventive strategies for childhood pneumonia.
- To investigate pathogen prevalence and load in relation to disease severity.
Main Methods:
- Prospective case-control study (PneumoWA) involving 500 children (250 cases, 250 controls).
- Cases: children with radiologically confirmed pneumonia; Controls: healthy children.
- Nasopharyngeal swabs analyzed by PCR for viral and bacterial detection; quantitative PCR used for pathogen load assessment.
Main Results:
- Prevalence of detected pathogens in cases versus controls will be compared.
- Odds Ratio (OR) of detection and population attributable fraction for each pathogen will be calculated.
- Relationships between pathogen load and disease status/severity will be explored.
Conclusions:
- Findings will clarify the role of specific bacteria and viruses in childhood CAP.
- Results will guide the development of targeted interventions for pneumonia prevention and treatment.
- This research addresses a critical gap in understanding pneumonia etiology in developed nations.
Introduction:
Pneumonia is the leading cause of childhood morbidity and mortality globally. Introduction of the conjugate Haemophilus influenzae B and multivalent pneumococcal vaccines in developed countries including Australia has significantly reduced the overall burden of bacterial pneumonia. With the availability of molecular diagnostics, viruses are frequently detected in children with pneumonia either as primary pathogens or predispose to secondary bacterial infection. Many respiratory pathogens that are known to cause pneumonia are also identified in asymptomatic children, so the true contribution of these pathogens to childhood community-acquired pneumonia (CAP) remains unclear. Since the introduction of pneumococcal vaccines, very few comprehensive studies from developed countries have attempted to determine the bacterial and viral aetiology of pneumonia. We aim to determine the contribution of bacteria and viruses to childhood CAP to inform further development of effective diagnosis, treatment and preventive strategies.
Methods And Analysis:
We are conducting a prospective case-control study (PneumoWA) where cases are children with radiologically confirmed pneumonia admitted to Princess Margaret Hospital for Children (PMH) and controls are healthy children identified from PMH outpatient clinics and from local community immunisation clinics. The case-control ratio is 1:1 with 250 children to be recruited in each arm. Nasopharyngeal swabs are collected from both cases and controls to detect the presence of viruses and bacteria by PCR; pathogen load will be assessed by quantitative PCR. The prevalence of pathogens detected in cases and controls will be compared, the OR of detection and population attributable fraction to CAP for each pathogen will be determined; relationships between pathogen load and disease status and severity will be explored.
Ethics And Dissemination:
This study has been approved by the human research ethics committees of PMH, Perth, Australia (PMH HREC REF 2014117EP). Findings will be disseminated at research conferences and in peer-reviewed journals.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
13:45A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
Published on: September 21, 2019
Related Concept Videos
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Viral Recombination
Western Blotting
The technique begins with separating proteins from the sample using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), followed by protein transfer, immunoblotting, and finally, protein detection.
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...